ArticleEuropean journal of cancer (Oxford, England : 1990)2025

Long-term outcomes among patients who respond within the first year to nivolumab plus ipilimumab or nivolumab monotherapy: A pooled analysis in 935 patients.

C Robert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.